u-blox High-Precision Positioning Solutions Now Available On NVIDIA(R) Jetson(TM) Edge AI and NVIDIA DRIVE Hyperion(TM) Platforms
THALWIL, SWITZERLAND / ACCESSWIRE / July 30, 2024 / u-blox (SIX:UBXN), a global provider of leading positioning and wireless communication technologies and services, has strengthened its contribution to the NVIDIA® Jetson™ and NVIDIA DRIVE Hyperion™ platforms as part of its strategic growth initiative around high-precision positioning within the industrial and automotive markets. u-blox has joined the NVIDIA Jetson Partner Ecosystem , which delivers the power of modern AI for autonomous machines and other edge AI applications across all industrial markets.
Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
Utilization of the Company's proprietary Web App showed improved self-selection utilizing an embedded validated diagnostic questionnaire compared to a live interview furthering the Company's efforts to potentially create a first-ever Rx-to-OTC switch in the ED category NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over-the-counter ("OTC") drug development programs, today announced results of a subsequent analysis of its pivotal study aimed at facilitating FDA-approved OTC access of the Company's STENDRA® (avanafil) for consumers. This analysis suggested support for the primary study results and demonstrated improved correct self-selection outcomes resulting from patients using the Company's proprietary Web App Technology and its embedded clinically validated diagnostic tool relative to subsequent verbal interviews that were designed into the study protocol as a form of validation of an ED diagnosis.
Ryder (R) Beats Q2 Earnings Estimates, Tweaks 2024 EPS View
Ryder (R) now expects its 2024 adjusted earnings guidance between $11.90 and $12.40 compared with the prior guided view of $11.75-$12.50.
Compared to Estimates, Ryder (R) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Ryder (R) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ryder (R) Q2 Earnings Top Estimates
Ryder (R) came out with quarterly earnings of $3 per share, beating the Zacks Consensus Estimate of $2.88 per share. This compares to earnings of $3.61 per share a year ago.
Ryder System, Inc. (R) Shareholders - L&K, LLP Encourages you to File a Claim Against the Settlement Fund Before Deadline
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Ryder System, Inc. (NYSE: R). The settlement provides for a fund of $45,000,000 to benefit class members.
Ryder (R) Gears Up to Report Q2 Earnings: What's in Store?
Ryder's (R) second-quarter 2024 revenues are expected to have benefited from strength across all segments. However, rising expenses are expected to have hurt its bottom line.
Looming Deadline - Levi & Korsinsky Encourages Shareholders of Ryder System, Inc. (R) to File a Share in Class Action Recovery
NEW YORK, NY / ACCESSWIRE / July 18, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Ryder System, Inc. (NYSE:R). The settlement provides for a fund of $45,000,000 to benefit class members.
Earnings Preview: Ryder (R) Q2 Earnings Expected to Decline
Ryder (R) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The United States Eventing Association Names Zomedica's PulseVet(R) as the Official Shock Wave of the USEA
Zomedica will sponsor a variety of high-profile events within the USEA ANN ARBOR, MI / ACCESSWIRE / July 17, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, is honored to announce that the United States Eventing Association, Inc. (USEA), a leading equestrian sports organization, has named PulseVet as the "Official Shock Wave of the USEA" for 2024. As part of its partnership with the USEA, PulseVet Shock Wave is also a "Gold Sponsor" of the USEA American Eventing Championships, "Bronze Sponsor" of the USEA Classic Series, and "Contributing Sponsor" of the USEA EA21 Program, the USEA Annual Meeting and Convention, and the USEA Adult Team Championships.
Ryder (R) to Gain From Pit Stop Acquisition: Here's How
The latest deal is expected to expand the presence of Ryder's (R) retail mobile maintenance business, Torque by Ryder, into 140 cities in 20 states.
Ryder System, Inc. (R) Shareholders - L&K, LLP Encourages you to File a Claim Against the Settlement Fund Before Deadline
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Ryder System, Inc. (NYSE:R). The settlement provides for a fund of $45,000,000 to benefit class members.
